Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CAPECITABINE Cause Gastrointestinal toxicity? 368 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 368 reports of Gastrointestinal toxicity have been filed in association with CAPECITABINE (Capecitabine). This represents 0.6% of all adverse event reports for CAPECITABINE.

368
Reports of Gastrointestinal toxicity with CAPECITABINE
0.6%
of all CAPECITABINE reports
48
Deaths
121
Hospitalizations

How Dangerous Is Gastrointestinal toxicity From CAPECITABINE?

Of the 368 reports, 48 (13.0%) resulted in death, 121 (32.9%) required hospitalization, and 13 (3.5%) were considered life-threatening.

Is Gastrointestinal toxicity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CAPECITABINE. However, 368 reports have been filed with the FAERS database.

What Other Side Effects Does CAPECITABINE Cause?

Diarrhoea (9,277) Nausea (6,248) Palmar-plantar erythrodysaesthesia syndrome (5,294) Fatigue (5,018) Death (4,422) Vomiting (4,111) Disease progression (3,808) Off label use (3,193) Malignant neoplasm progression (2,425) Asthenia (2,352)

What Other Drugs Cause Gastrointestinal toxicity?

FLUOROURACIL (358) METHOTREXATE (345) OXALIPLATIN (314) CYCLOPHOSPHAMIDE (266) RITUXIMAB (262) CISPLATIN (251) DOXORUBICIN (242) IRINOTECAN (232) CARBOPLATIN (231) BORTEZOMIB (208)

Which CAPECITABINE Alternatives Have Lower Gastrointestinal toxicity Risk?

CAPECITABINE vs CAPIVASERTIB CAPECITABINE vs CAPLACIZUMAB CAPECITABINE vs CAPLACIZUMAB-YHDP CAPECITABINE vs CAPMATINIB CAPECITABINE vs CAPREOMYCIN

Related Pages

CAPECITABINE Full Profile All Gastrointestinal toxicity Reports All Drugs Causing Gastrointestinal toxicity CAPECITABINE Demographics